{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:19:44Z","timestamp":1782217184592,"version":"3.54.5"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000149","name":"Canadian Association of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbvie Canada"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Existing measures of inflammatory bowel disease (IBD) symptoms are not well suited to self-report, inadequate in measurement properties, insufficiently specific, or burdensome for brief or repeated administration. We aimed to develop a patient-reported outcome measure to assess a broader range of IBD symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The IBD Symptoms Inventory (IBDSI) was developed by adapting symptom items from existing clinician-rated or diary-format inventories; after factor analysis, 38 items were retained on 5 subscales: bowel symptoms, abdominal discomfort, fatigue, bowel complications, and systemic complications. Participants completed the IBDSI and other self-report measures during a clinic visit. A nurse administered the Harvey Bradshaw Index (HBI) for Crohn\u2019s disease (CD) or the Powell-Tuck Index (PTI) for ulcerative colitis (UC), and a gastroenterologist completed a global assessment of disease severity (PGA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 267 participants with CD (n = 142) or UC (n = 125), ages 18 to 81 (M = 43.4, SD = 14.6) were 58.1% female, with a mean disease duration of 13.9 (SD = 10.5) years. Confirmatory factor analysis supported the 5 subscales. The total scale and subscales showed good reliability and significant correlations with self-report symptom and IBD quality of life measures, the HBI, PTI, and PGA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The IBDSI showed strong measurement properties: a supported factor structure, very good internal consistency, convergent validity, and excellent sensitivity and specificity to clinician-rated active disease. Self-report HBI and PTI items, when extracted from this measure, produced scores comparable to clinician-administered versions. The 38-item IBDSI, or 26-item short form, can be used as a brief survey of common IBD symptoms in clinic or research settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izz038","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T22:19:44Z","timestamp":1553725184000},"page":"1277-1290","source":"Crossref","is-referenced-by-count":44,"title":["The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application"],"prefix":"10.1093","volume":"25","author":[{"given":"Kathryn A","family":"Sexton","sequence":"first","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Clinical Health Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Clinical Health Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Targownik","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A","family":"Graff","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Clinical Health Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clove","family":"Haviva","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E","family":"Beatie","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K","family":"Petty","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Clinical Health Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norine","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-3574","authenticated-orcid":false,"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"2019071705263471800_CIT0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National cooperative Crohn\u2019s disease study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology."},{"key":"2019071705263471800_CIT0002","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet."},{"key":"2019071705263471800_CIT0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut."},{"key":"2019071705263471800_CIT0004","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365527809182199","article-title":"A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis","volume":"13","author":"Powell-Tuck","year":"1978","journal-title":"Scand J Gastroenterol."},{"key":"2019071705263471800_CIT0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrgastro.2016.128","article-title":"Current best practice for disease activity assessment in IBD","volume":"13","author":"Walsh","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2019071705263471800_CIT0006","first-page":"2460","article-title":"Systematic review of the clinical disease severity indices for inflammatory bowel disease","volume":"21","author":"Alrubaiy","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2019071705263471800_CIT0007","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2017.10.019","article-title":"Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review","volume":"16","author":"de Jong","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019071705263471800_CIT0008","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","article-title":"Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn\u2019s disease (SES-CD) than CRP, blood leukocytes, and the CDAI","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"2019071705263471800_CIT0009","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/00365521.2012.660542","article-title":"Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn\u2019s disease","volume":"47","author":"af Bj\u00f6rkesten","year":"2012","journal-title":"Scand J Gastroenterol."},{"key":"2019071705263471800_CIT0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MIB.0000000000000341","article-title":"Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission","volume":"21","author":"Falvey","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2019071705263471800_CIT0011","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.3748\/wjg.v21.i40.11469","article-title":"Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?","volume":"21","author":"Boon","year":"2015","journal-title":"World J Gastroenterol."},{"key":"2019071705263471800_CIT0012","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2015.147","article-title":"The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease","volume":"110","author":"Targownik","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"2019071705263471800_CIT0013","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MIB.0000000000001040","article-title":"Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease","volume":"23","author":"Sexton","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"2019071705263471800_CIT0014","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.gtc.2017.08.016","article-title":"Diet as a therapeutic option for adult inflammatory bowel disease","volume":"46","author":"Kakodkar","year":"2017","journal-title":"Gastroenterol Clin North Am."},{"key":"2019071705263471800_CIT0015","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cgh.2013.09.063","article-title":"Diet and inflammatory bowel disease: review of patient-targeted recommendations","volume":"12","author":"Hou","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019071705263471800_CIT0016","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol."},{"key":"2019071705263471800_CIT0017","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/ajg.2009.197","article-title":"The Manitoba IBD index: evidence for a new and simple indicator of IBD activity","volume":"104","author":"Clara","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"2019071705263471800_CIT0018","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology."},{"key":"2019071705263471800_CIT0019","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav."},{"key":"2019071705263471800_CIT0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1037\/1040-3590.12.1.102","article-title":"On the sins of short-form development","volume":"12","author":"Smith","year":"2000","journal-title":"Psychol Assess."},{"key":"2019071705263471800_CIT0021","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual Life Res."},{"key":"2019071705263471800_CIT0022","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biom J."},{"key":"2019071705263471800_CIT0023","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/1082-989X.3.4.424","article-title":"Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification","volume":"3","author":"Hu","year":"1998","journal-title":"Psycholog Meth"},{"key":"2019071705263471800_CIT0024","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"2019071705263471800_CIT0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11938-017-0130-6","article-title":"Treat to target in inflammatory bowel disease: an updated review of literature","volume":"15","author":"Darr","year":"2017","journal-title":"Curr Treat Options Gastroenterol."},{"key":"2019071705263471800_CIT0026","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.cgh.2013.03.031","article-title":"Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors","volume":"11","author":"Graff","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019071705263471800_CIT0027","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cgh.2014.02.016","article-title":"Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease","volume":"12","author":"Williet","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019071705263471800_CIT0028","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/ajg.2014.237","article-title":"Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales","volume":"109","author":"Spiegel","year":"2014","journal-title":"Am J Gastroenterol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izz038\/28928612\/izz038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/8\/1277\/28940266\/izz038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T15:45:51Z","timestamp":1568994351000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/25\/8\/1277\/5421080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,3,27]]},"published-print":{"date-parts":[[2019,7,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izz038","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,3,27]]}}}